Interní Med. 2009; 11(7): 336-339

Secondary hypertension

MUDr. Tomáš Zelinka
III. interní klinika VFN a 1. LF UK, Praha, Centrum pro výzkum, diagnostiku a terapii arteriální hypertenze

Hypertension as a sign of other disease is called secondary hypertension. In some cases, early diagnose and treatment may lead to

a complete cure or at least to a dramatic improvement of hypertension. The most typical form of secondary hypertension is endocrine

hypertension, in particular primary aldosteronism and less frequently pheochromocytoma, Cushing syndrome or very rarely acromegalia

and primary hyperparathyreosis. The other causes are renovascular hypertension, renoparenchymatous hypertension, sleep

apnoe syndrome, aortic coarctation or hypertension due to an intracranial tumor. Suspicion on secondary hypertension should arise

when hypertension is resistant to the treatment or when other symptoms or signs typical for diseases associated with hypertension are

present, e.g. hypokalemia, paroxysmal symptoms, and sleep disturbances.

Keywords: primary aldosteronism, pheochromocytoma, hypercortisolism, renovascular hypertension.

Published: September 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zelinka T. Secondary hypertension. Interní Med. 2009;11(7):336-339.
Download citation

References

  1. Widimský J, a kol. Hypertenze. Praha: Triton 2008: 705 s.
  2. Widimský J jr., et al. Doporučení diagnostických a léčebných postupů u arteriální hypertenze - verze 2007. Doporučení České společnosti pro hypertenzi. Vnitř Lék 2008; 54: 101-110, 12, 14-18. Go to PubMed...
  3. Redon J, et al. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 1998; 31: 712-718. Go to original source... Go to PubMed...
  4. Calhoun DA, et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51: 1403-1419. Go to original source... Go to PubMed...
  5. Funder JW, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guidelines. J Clin Endocrinol Metab 2008; 93: 3266-3281. Go to original source... Go to PubMed...
  6. Štrauch B, et al. Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. J Hum Hypertens 2003; 17: 349-352. Go to original source... Go to PubMed...
  7. Pacák K. Feochromocytom. Praha: Galén 2008: s. 177.
  8. Kršek M, Hána V. Cushingův syndrom. Praha: Galén 2007: s. 144.
  9. Newell-Price, et al. Cushing's syndrome. Lancet 2006; 367: 1605-1617. Go to original source... Go to PubMed...
  10. Hackam DG, et al. Role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertension. Hypertension 2007; 50: 998-1003. Go to original source... Go to PubMed...
  11. Logan AG, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001; 19: 2271-2277. Go to original source... Go to PubMed...
  12. Kapa S, et al. Sleep apnea and hypertension: interactions and implications for management. Hypertension 2008; 51: 605-608. Go to original source... Go to PubMed...
  13. Zelinka T, et al. Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice. Stress 2007; 10: 195-203. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.